Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Jasper Joye
Profile
Projects
Publications
Activities
Awards & Distinctions
3
Results
2023
Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine
Isabel Leroux-Roels
Jacques Bruhwyler
Lilli Stergiou
Mark Sumeray
Jasper Joye
Cathy Maes
Paul-Henri Lambert
Geert Leroux-Roels
A1
Journal Article
in
VACCINES
2023
2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Isabel Leroux-Roels
Cathy Maes
Jasper Joye
Bart Jacobs
Franziska Jarczowski
André Diessner
Yorick Janssens
Gwenn Waerlop
Kirsi Tamminen
Suvi Heinimäki
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2022
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
Yorick Janssens
Jasper Joye
Gwenn Waerlop
Frédéric Clement
Geert Leroux-Roels
Isabel Leroux-Roels
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2022